Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
48.47 USD | -0.47% | -0.98% | +5.95% |
14/05 | Transcript : Belite Bio, Inc, Q1 2024 Earnings Call, May 14, 2024 | |
14/05 | Belite Bio, Inc Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.95% | 144.41Cr | |
+51.85% | 5.79TCr | |
+41.42% | 4.03TCr | |
-5.25% | 3.99TCr | |
-5.16% | 2.85TCr | |
+12.79% | 2.64TCr | |
-20.18% | 1.93TCr | |
+30.88% | 1.24TCr | |
+0.61% | 1.22TCr | |
+25.06% | 1.22TCr |
- Stock Market
- Equities
- BLTE Stock
- News Belite Bio, Inc
- Belite Bio Finalizes Study Design for Late-Stage Trial of Tinlarebant to Treat Geographic Atrophy Associated with Dry AMD